EGFR variant allele frequency predicts EGFR-TKI efficacy in lung adenocarcinoma: a multicenter study

Gieszer, B; Megyesfalvi, Z; Dulai, V; Papay, J; Kovalszky, I; Timar, J; Fillinger, J; Harko, T; Pipek, O; Teglasi, V; Regos, E; Papp, G; Szallasi, Z; Laszlo, V; Renyi-Vamos, F; Galffy, G; Bodor, C; Dome, B; Moldvay, J

Dome, B (corresponding author), Med Univ Vienna, Comprehens Canc Ctr, Dept Thorac Surg, Waehringer Guertel 18-20, A-1090 Vienna, Austria.; Megyesfalvi, Z (corresponding author), Semmelweis Univ, Dept Thorac Surg, Natl Inst Oncol, Rath Gyorgy U 7-9, H-1122 Budapest, Hungary.

TRANSLATIONAL LUNG CANCER RESEARCH, 2021; 10 (2): 662

Abstract

Background: Although lung adenocarcinoma (LADC) with sensitizing mutations of the epidermal growth factor receptor (EGFR) is highly sensitive to EGFR ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索